2023EBC | Diffei Medical & MGI, empowering the 'new' era of pathogen detection
Precision medicine, testing first. On March 18, at the 2023EBC Eighth Yimao Bio Industry Conference, MGI held the 'DNBSEQ-G99 Signing Ceremony'. Diffei Medical and MGI have officially reached a cooperation to jointly develop application expansion based on G99 to facilitate accurate detection of infectious pathogens and empower high-quality clinical development!
Difei Academic | mNGS reveals changes in intestinal flora and related drug resistance genes in children in PICU after antibiotic treatment
Recently, Difei Medical collaborated with the team of Zhu Xiaodong, PICU of Xinhua Hospital Affiliated to Shanghai Jiao Tong University, and published 'Pediatric intensive care unit treatment alters the diversity and composition of the gut microbiota and antimicrobial resistance gene expression in critical' in Frontiers in Microbiology (IF=5.200) ill children》.The article comprehensively reveals the community structure of the intestinal flora of children in PICU, and compares the differences in intestinal flora, gene functions, and changes in metabolism-related pathways in children before and after short-term antibiotic treatment.
Diffei Academic | mNGS reveals the role of lung microbiota in primary graft dysfunction in lung transplant recipients
Recently, the Department of Respiratory and Critical Care Medicine of the China-Japan Friendship Hospital cooperated with Diffei Medical to conduct mNGS detection on the bronchoalveolar lavage fluid of 32 patients with lung transplantation and primary graft dysfunction (PGD) to explore the The role of local microbiota in lung transplant patients complicated with PGD.Studies have shown that there are changes in the lung flora of patients with PGD grade 3, and the imbalance of lung flora is related to lung immunity.The research results have been published in The Journal of Clinical and Transplantation Research.
